Faller Douglas Vincent 4
4 · Imunon, Inc. · Filed Jul 21, 2026
Research Summary
AI-generated summary of this filing
Imunon (IMNN) CMO Douglas Faller Receives 3,082-Share Award
What Happened
Douglas Vincent Faller, Chief Medical Officer of Imunon, Inc. (IMNN), received an award of 3,082 shares on July 17, 2026. The shares were reported at $1.83 each, valuing the grant at approximately $5,640. This was an acquisition via award (transaction code A) — stock granted in lieu of a portion of base salary.
Key Details
- Transaction date: 2026-07-17
- Filing date: 2026-07-21 (filed within the Form 4 two-business-day window)
- Shares granted: 3,082
- Price reported: $1.83 per share
- Total value: ~$5,640
- Footnote: stock granted in lieu of cash for portion of base salary (per filing)
- Shares owned after the transaction: not specified in the provided filing
Context
This was a compensation-related stock award, not an open-market purchase or sale. Awards in lieu of cash are a routine form of executive compensation and do not, by themselves, indicate buying or selling sentiment.
Insider Transaction Report
Form 4
Imunon, Inc.IMNN
Faller Douglas Vincent
Chief Medical Officer
Transactions
- Award
Common Stock
[F1]2026-07-17$1.83/sh+3,082$5,640→ 26,286 total
Footnotes (1)
- [F1]Stock granted in lieu of cash for portion of base salary
Signature
/s/ Susan Eylward, Attorney-in-Fact for Douglas Faller|2026-07-21